These findings are in agreement with recent studies showing that CB2 activation, by ECs and their analogue lipid mediators, protects against oxidative stress-induced tissue damage in experimental models of I/R injury [191,192,193,194,195], cardiovascular inflammation, and/or atherosclerosis [191,196,197]. The gene discussed is CNR2; the disease is atherosclerosis.